Ventilator Associated Pneumonia Clinical Trial
Official title:
Safe Critical Care: Testing Improvement Strategies
Verified date | December 2015 |
Source | Vanderbilt University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
One group of hospitals participated in a collaborative approach for healthcare quality improvement while another group was provided only a tool kit. The investigators' objective was to determine if the Collaborative would perform better at preventing central line-associated bloodstream infections (CLABSI) and ventilator-associated pneumonias (VAP). Hospitals were randomized to the Tool Kit or Collaborative conditions. The investigators' study evaluated the effects on care processes and outcomes of a multi-institutional quality improvement initiative focused on preventing hospital associate infections. The investigators' hypothesis was that the strategies for implementing safe critical care practice will differ in level of achievement whereby the Collaborative group will perform better than the Tool Kit group. The outcome measure comprised clinical event rates and an index of safe practices that represent a bundling of key process measures related to evidence-based practices for preventing catheter-related blood-stream infections and ventilator-associated pneumonia in the intensive care unit.
Status | Completed |
Enrollment | 59 |
Est. completion date | April 2008 |
Est. primary completion date | April 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 1 Year and older |
Eligibility |
Inclusion Criteria: - Medical centers with at least one adult or pediatric ICU. - Medical centers within the Hospital Corporation of America (HCA) were eligible for enrollment. Exclusion Criteria: - Nonresponse to invitation to participate in our Safe Critical Care Initiative. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | HCA Hospital Corporation of America | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Vanderbilt University |
United States,
France DJ, Greevy RA Jr, Liu X, Burgess H, Dittus RS, Weinger MB, Speroff T. Measuring and comparing safety climate in intensive care units. Med Care. 2010 Mar;48(3):279-84. doi: 10.1097/MLR.0b013e3181c162d6. — View Citation
Patel RP, Gambrell M, Speroff T, Scott TA, Pun BT, Okahashi J, Strength C, Pandharipande P, Girard TD, Burgess H, Dittus RS, Bernard GR, Ely EW. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare profess — View Citation
Speroff T, Ely EW, Greevy R, Weinger MB, Talbot TR, Wall RJ, Deshpande JK, France DJ, Nwosu S, Burgess H, Englebright J, Williams MV, Dittus RS. Quality improvement projects targeting health care-associated infections: comparing Virtual Collaborative and — View Citation
Talbot TR, Tejedor SC, Greevy RA, Burgess H, Williams MV, Deshpande JK, McFadden P, Weinger MB, Englebright J, Dittus RS, Speroff T. Survey of infection control programs in a large national healthcare system. Infect Control Hosp Epidemiol. 2007 Dec;28(12) — View Citation
Wall RJ, Ely EW, Talbot TR, Weinger MB, Williams MV, Reischel J, Burgess LH, Englebright J, Dittus RS, Speroff T, Deshpande JK. Evidence-based algorithms for diagnosing and treating ventilator-associated pneumonia. J Hosp Med. 2008 Sep;3(5):409-22. doi: 1 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | CLABSI and VAP Rates | Central line associated bloodstream infections(CLABSI) and ventilator associated pneumonias (VAP) using Centers for Disease Control and Prevention definitions as number of events per 1,000 device days, data collection and surveillance methods. | 18 Months: 3-month baseline and quarterly post-intervention periods | Yes |
Secondary | Access of Tools and Use of Quality Improvement Strategies | Follow-up survey of ICU nurse and quality managers for all participating medical centers from Jan 2008 through April 2008 included questions about the implementation of process interventions: Access and use of clinical guidelines tools, access and use of quality improvement tools, and types of quality improvement implementation strategies. | 18 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03937947 -
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
|
||
Not yet recruiting |
NCT04057625 -
Transthoracic Ultrasound in the Diagnosis and Follow-up of Ventilator Associated Pneumonia
|
N/A | |
Not yet recruiting |
NCT03267693 -
Gastrointestinal Complications in Association With Oropharyngeal and Respiratory Infections in Mechanical Ventilation
|
N/A | |
Completed |
NCT00726167 -
Serum Procalcitonin Study in the Management of Ventilated Patients
|
N/A | |
Completed |
NCT02078999 -
Biomarkers in Patients Undergoing Mechanical Ventilation
|
N/A | |
Recruiting |
NCT05124977 -
Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care
|
N/A | |
Recruiting |
NCT05331885 -
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
|
Phase 3 | |
Completed |
NCT05517759 -
Application of VAP Bundle Among ICU Nurses
|
||
Active, not recruiting |
NCT04488510 -
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
|
||
Completed |
NCT03917888 -
Clinical Impact of Lung Ultrasound Monitoring for Diagnosis of VAP
|
N/A | |
Not yet recruiting |
NCT06066489 -
Effect of Educational Program About Preventive Care Bundle for Prevention of Ventilator Associated Pneumonia Among Newborns
|
N/A | |
Completed |
NCT02096328 -
Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia
|
Phase 2 | |
Terminated |
NCT00771719 -
Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
|
Phase 1 | |
Recruiting |
NCT05696093 -
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
|
Phase 3 | |
Recruiting |
NCT05354778 -
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
|
N/A | |
Not yet recruiting |
NCT06059040 -
Effect of Eliminating Gastric Residual Volume Monitoring on Ventilator Associated Events
|
N/A | |
Completed |
NCT04563104 -
Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated Pneumonia
|
||
Terminated |
NCT01975350 -
Efficacy Study of Colistimethate Sodium Inhalation in Patients With Ventilator-associated Pneumonia
|
||
Recruiting |
NCT06000761 -
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
|
N/A | |
Not yet recruiting |
NCT03294837 -
Treatment of Ventilator Associated Pneumonia in Pediatric Intensive Care Unit
|
N/A |